STOCK TITAN
  1. Home
  2. Sec-filings
  3. VCYT
  4. [Form 4] Veracyte, Inc. Insider Trading Activity

VCYT Form 4: 3,507 Shares Withheld for Taxes; Insider Owns 93,882 Shares

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Annie McGuire, SVP and General Counsel of Veracyte, Inc. (VCYT), reported that 3,507 shares of common stock were withheld on 09/02/2025 to satisfy tax withholding tied to the vesting of restricted stock units; this withholding is not a sale and was executed at a per-share price of $30.11. After the withholding, McGuire beneficially owned 93,882 shares, which includes 386 shares purchased on 07/31/2025 under the company’s Employee Stock Purchase Plan. The Form 4 was filed by one reporting person and signed by an attorney-in-fact on 09/04/2025.

Positive

  • Shares withheld for tax indicate RSU vesting rather than an open-market sale, suggesting continued equity compensation alignment with the company
  • Employee Stock Purchase Plan purchase of 386 shares shows additional insider participation in company equity

Negative

  • Beneficial ownership decreased by 3,507 shares due to tax withholding, reducing the reporting person's reported share count
  • No information on remaining unvested awards is provided, limiting assessment of future insider dilution or vesting cadence

Insights

TL;DR: Routine tax-withholding on vested RSUs; no open-market sale indicated, minimal governance concern.

The Form 4 shows a common administrative action: shares were withheld to satisfy tax obligations on vested restricted stock units. This reduces the reporting person’s nominal share count but does not represent a disposition to a third party or a change in insider intent. For governance review, the key points are the transaction code and the explicit explanation that the withholding "does not represent a sale," which aligns with standard equity compensation practices and does not signal insider liquidity.

TL;DR: Small, non-market transaction; immaterial to company float or insider conviction.

The withheld amount of 3,507 shares at $30.11 per share reflects tax-settlement of RSUs and leaves the reporting person with 93,882 shares outstanding beneficially. The filing also discloses a separate, small ESPP purchase of 386 shares on 07/31/2025. These items are routine and unlikely to affect liquidity or signal material changes in insider expectations. No derivative transactions or sales were reported.

Insider McGuire Annie
Role SVP, General Counsel
Type Security Shares Price Value
Tax Withholding Common Stock 3,507 $30.11 $106K
Holdings After Transaction: Common Stock — 93,882 shares (Direct)
Footnotes (1)
  1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2025 and does not represent a sale. Includes 386 shares of common stock purchased on July 31, 2025 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
McGuire Annie
(Last) (First) (Middle)
6000 SHORELINE COURT, SUITE 300
(Street)
SOUTH SAN FRANCISCO CA 94080
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, General Counsel
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/02/2025 F(1) 3,507 D $30.11 93,882(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2025 and does not represent a sale.
2. Includes 386 shares of common stock purchased on July 31, 2025 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.
Remarks:
/s/ Jonathan Wygant, as attorney-in-fact 09/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What transaction did Annie McGuire (VCYT) report on Form 4?

The filing reports that 3,507 shares were withheld on 09/02/2025 to satisfy tax withholding tied to vested restricted stock units; this is not a sale.

How many shares does the reporting person beneficially own after the transaction?

After the withholding, the reporting person beneficially owns 93,882 shares.

Did the Form 4 disclose any purchases by the reporting person?

Yes. The filing states 386 shares were purchased on 07/31/2025 under Veracyte’s Employee Stock Purchase Plan.

What price was used in the tax-withholding transaction?

The withholding was reported with a per-share price of $30.11.

Does this Form 4 indicate an open-market sale by the insider?

No. The explanation explicitly states the shares were withheld to satisfy tax obligations and do not represent a sale.